BullFrog AI Holdings, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation NV
Business Address 325 ELLINGTON BLVD., GAITHERSBURG, MD, 20878
Mailing Address 325 ELLINGTON BLVD., GAITHERSBURG, MD, 20878
Phone 3013672055
Fiscal Year End 1231
EIN 844786155
Financial Overview
FY2024
$-0.85
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 23, 2026 | View on SEC |
| 8-K Current report of material events | February 17, 2026 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 424B5 Prospectus supplement | November 7, 2025 | View on SEC |
| 8-K Current report of material events | October 24, 2025 | View on SEC |
| S-1 IPO registration statement | October 10, 2025 | View on SEC |
| 8-K Current report of material events | October 9, 2025 | View on SEC |
| 4 Insider stock transaction report | September 29, 2025 | View on SEC |
| 4 Insider stock transaction report | September 29, 2025 | View on SEC |
Material Events
8-K Financial Distress February 23, 2026
High Impact
- BullFrog AI leverages AI for drug discovery, operating in a high-potential sector.
- The company plans to request a hearing before an independent Nasdaq Hearings Panel, temporarily halting the delisting process.
8-K Financial Distress February 17, 2026
High Impact
- BullFrog AI leverages Artificial Intelligence (AI) for drug discovery, a promising and innovative field.
- The company has stated its intention to monitor its stock price and evaluate all available options to restore Nasdaq compliance.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.